Minoryx Therapeutics S.l.

Johannes B M Rewinkel

Wolter Ten Hoeve

Ana Maria García Collazo

Johannes Nicolaas Koek

Sander De Wilde

The disclosure provides a process of making the compound of Formula I, and pharmaceutically acceptable salts thereof; and the process of making the intermediate of Formula III; wherein PG is as defined as set forth in the specification.

Process for preparing 5-[[4-[2-[5-(1-hydroxyethyl)-2-pyridinyl]ethoxy]phenyl]-methyl]-2,4-thiazolidinedione and salts thereof

The disclosure provides a process of making the compound of Formula I, and pharmaceutically acceptable salts thereof: and the process of making the intermediate of Formula III: wherein PG is as defined as set forth in the specification. 

Growing community of inventors

Oss, Netherlands

Johannes B M Rewinkel